| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Bharat Brijmohan Sharma CEO | MSE Exchange | INE615T01017 ISIN |
| India Country | 19 Employees | 16 Mar 2022 Last Dividend | - Last Split | - IPO Date |
Ganga Pharmaceuticals Ltd. stands out as a leading entity in the pharmaceutical realm, with its core focus on the development, production, and distribution of both generic and branded pharmaceuticals. The essence of the company's operation lies in its dedication to crafting high-quality medications that adhere to the strictest of regulatory standards, ensuring a broad spectrum of individuals have access to much-needed health solutions. With its footprints across the global healthcare, biotechnology, and life sciences sectors, Ganga Pharmaceuticals plays a critical role in offering vital drugs aimed at a variety of medical conditions, hence supporting comprehensive patient care needs. By maintaining a substantial presence in various markets around the world, both emerging and established, the company is pivotal in fostering innovation and enhancing the accessibility of pharmaceuticals. Ganga Pharmaceuticals is celebrated for its robust commitment to research and development, which propels the continuous enlargement of its product range, securing its ongoing growth and relevance within the market.